Cytokine and Visual Outcome Variations in Eyes Receiving Aflibercept

Clinical trial NCT03056079 · UNKNOWN

Trial details

NCT number: NCT03056079
Sponsor: Unity Health Toronto
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Age Related Macular Degeneration Diabetic Macular Edema Retinal Vein Occlusion Macular Edema

Start date: 2017-02-28
Primary completion: 2024-02-28
Enrollment: 168

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.